Compare ARK Genomic Revolution ETF (ARKG) vs GE Vernova Inc (GEV) Price & Performance
Price performance
Price movement over the last 24 hours
Key statistics
Key statistics
ARK Genomic Revolution ETF vs GE Vernova Inc — how do they compare? ARK Genomic Revolution ETF trades at $40.83, while GE Vernova Inc trades at $1,080.36 (market cap $293.33B). The key difference: GE Vernova Inc pays a 0.18% dividend while ARK Genomic Revolution ETF pays none. Which is the better fit depends on your goals.
| ARKG | GEV | |
|---|---|---|
Sector | Sector/Thematic | Technology |
52-Week High | $43.57 | $1.17K |
52-Week Low | $23.09 | $539.16 |
Market Cap | — | $293.33B |
Enterprise Value | — | $285.96B |
Dividend Yield | — | 0.18% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
ARKG trades at $41.32, down 3.91% today, with a bullish technical signal driven by moving averages. Recent news highlights biotech ETF strength in June 2026, fueled by strong earnings, M&A activity, and AI-driven drug discovery optimism. Key support lies at $40, with resistance at $44.
The outlook remains positive given sector tailwinds, but risks include regulatory hurdles and market volatility. Investor sentiment is buoyed by industry growth catalysts, though selective investment approaches are noted by analysts.
GE Vernova (GEV) trades at $1,091.57, up 1.52% with strong analyst support (75% buy ratings) and a consensus price target of $1,230. The stock shows bullish technical momentum with recent earnings beats and robust profitability metrics including 23.81% net income margin and 83.23% ROE. Recent news highlights the company's strategic positioning in AI power infrastructure and nuclear energy expansion.
Outlook remains positive with projected revenue growth to $39.4B and net profit doubling to $9.4B in 2026. Key risks include high valuation multiples (P/E 31.9, EV/EBITDA 113.7) and execution challenges in scaling nuclear operations. The stock offers exposure to AI-driven power demand but faces volatility from energy market fluctuations.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About ARK Genomic Revolution ETF
ARKG is an actively managed ETF that invests in the genomic revolution. It focuses on companies leading in gene editing, CRISPR technology, therapeutics, and molecular diagnostics, including firms like CRISPR Therapeutics and Tempus AI.
Read more on ARKG →About GE Vernova Inc
GE Vernova is a global leader in the electric power industry. It provides sustainable energy solutions across gas, wind, and hydro sectors, focusing on modernizing the world's power grids.
Read more on GEV →
